Optima Capital’s DexCom DXCM Stock Holding History

Optima Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-91	Closed	-$6.04K	–	477
2025 Q4	$6.04K	Buy	+91	New	+$5.88K	﹤0.01%	591

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Optima Capital's DXCM Position: Q1 2026 in Review

Optima Capital sold out of DexCom (DXCM) in Q1 2026, closing a stake of 91 shares — an estimated $6.04K sold.

Optima Capital first reported a position in DXCM in Q4 2025 and held it in 1 quarter. The position peaked at $6.04K in Q4 2025. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Optima Capital reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Optima Capital sold 91 DexCom shares in Q1 2026, an estimated $6.04K.
Optima Capital first reported a position in DexCom in Q4 2025 and held it in 1 quarter.
Optima Capital's DexCom position peaked at $6.04K in Q4 2025.
960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Optima Capital's 13F filing for Q1 2026, filed 5 May 2026.